Pharmacist Moms Group^™

Explore the promising data on elinzanetant for managing menopause-related vasomotor symptoms, highlighting its tolerability and minimal side effects.

Samantha Picking, PharmD, highlights pharmacists’ leadership in immunization initiatives, public health collaborations, and the evolving role of community pharmacy in preventive care.

Megan Dulohery Scrodin, MD, highlights Mayo Clinic's innovative COPD care model, emphasizing multidisciplinary collaboration and AI tools for improved patient outcomes.

Experts discuss breakthroughs in respiratory virus vaccines.

Elinzanetant shows promise as a new treatment for menopause-related vasomotor symptoms, offering rapid relief and a favorable safety profile.

Panelists discuss the long-term safety and durability of CDK4/6 inhibitors, highlighting data supporting sustained efficacy and manageable toxicity over years of treatment.

Panelists discuss how differences in dosing schedules, adherence challenges, and total duration of CDK4/6 inhibitor therapy impact patient management, treatment decisions, and quality of life in both advanced and early-stage settings.

Panelists discuss best practices for patient education and engagement when introducing CDK4/6 inhibitors in metastatic breast cancer care.